FROM RESEARCH TO ACCESS: How to Accelerate the Availability of Medicines for Unmet Needs?
The Fondazione Gianni Benzi will host the XVII edition of the Foresight Training Course (FTC), taking place online on 3-4 November 2025. The course, aimed at professionals in clinical research, health policy, and regulatory institutions, will focus on current challenges and advancements in clinical research, with the goal of addressing unmet medical needs.
The event will explore innovative topics such as emerging methodologies, regulatory challenges, and the involvement of adolescents in clinical trials. The financing of research and investment management will also be examined, with a particular focus on public incentives and public-private funding at the European, national, and regional levels. The course will also cover issues related to drug access, including joint procurement, national policies, Health Technology Assessment (HTA), and patient involvement in decision-making and access procedures.
To register for the course, please click HERE and to read the agenda, please click HERE.
TEDDY’s contribution in Session 1 – Advancements in Clinical Research taking place on 3 November:
A key highlight of the event will be the presentation of the “Accelerating Clinical Trials in the European Union (ACT EU) initiative for pediatric research” by Dr. Donato Bonifazi, representative of TEDDY and permanent member of the ACT EU Multi-stakeholder platform Advisory Group (MSP AG). Dr. Donato Bonifazi will highlight TEDDY’s role in the ACT EU initiative, emphasizing strategies to simplify clinical trial governance foster collaboration among key stakeholders. Dr. Donato Bonifazi will explore how TEDDY is driving change in clinical trials for small populations, promoting the accelerated introduction of medicines and devices that address unmet medical needs.
In the same session, Dr. Giorgio Reggiardo, chair of the TEDDY Working Group on Paediatric Research Methodologies, will deliver a presentation titled “Application of innovative methodologies and technologies: gaps and synergies between US and EU”, providing an analysis of these approaches, and exploring the gaps and potential synergies between the United States and the European Union.
Additionally in Session 1, Valentina Jalby, a young patient involved in the Patients Expert Group (PEG) of the INVENTS Project will share her unique experience of participating in European-funded projects and discuss the importance of involving adolescents in clinical trials with the presentation titled “Showcasing the experience of involving adolescents in European funded projects and reviewing clinical study tools”.
The INVENTS project focuses on improving research methodologies for rare diseases, with an emphasis on safely including small patient populations in clinical trials. TEDDY plays a key role in addressing ethical and regulatory challenges, particularly in ensuring the inclusion of young patients. As part of this, TEDDY established the PEG to empower adolescents with chronic conditions, such as Juvenile Idiopathic Arthritis (JIA) and Multiple Sclerosis (MS), to stay informed about advancements in research and to guarantee that young patients’ voices are heard in decision-making processes. The PEG launched with a two-day training course in Bari (Nov 1-3, 2024) for paediatric patients, following this, the PEG participated in six online sessions throughout 2025 to deepen their understanding of clinical trial methodologies and data strategies.
The event will feature prominent speakers from the regulatory, academic, and other key stakeholder sectors, providing a unique opportunity for updates and discussion.
For more information about the event, please click HERE. See the event on LinkedIn at the following LINK.